Marlene and Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, MD, USA.
Immunology. 2009 Dec;128(4):543-55. doi: 10.1111/j.1365-2567.2009.03140.x.
Leucocyte-associated immunoglobulin-like receptor-1 (LAIR-1) is a membrane receptor of the immunoglobulin (Ig) superfamily that is expressed on most types of haematopoietic cells, and delivers inhibitory signals through interacting with collagens. In order to elucidate the immunological functions of LAIR-1 in vivo, we established transgenic mice expressing a chimeric protein composed of the extracellular domain of LAIR-1 fused with an Ig tag (LAIR-1-Ig), which acts as a decoy by competing with endogenous LAIR-1. The transgenic mice showed an increased susceptibility for development of contact hypersensitivity (CHS), an experimental model of allergic contact dermatitis, in association with enhanced hapten-specific T-cell responses. When T cells from the hapten-sensitized donor mice were transferred into non-sensitized recipients, treatment of either donor mice or recipient mice with LAIR-1-Ig protein accelerated CHS, suggesting a potentially negative role of LAIR-1 in both the sensitization and the elicitation of hapten-reactive T cells. In vitro assays revealed that LAIR-1 decreased the production of interleukin-6 and interleukin-12 in dendritic cells, and inhibited the proliferation and cytokine production of naïve and memory T cells along with G(0)/G(1) cell cycle arrest. Collectively, our findings suggest that LAIR-1 plays a crucial inhibitory role in CHS by regulating antigen-presenting cell and T-cell functions.
白细胞相关免疫球蛋白样受体-1(LAIR-1)是免疫球蛋白(Ig)超家族的一种膜受体,在大多数类型的造血细胞上表达,并通过与胶原相互作用传递抑制信号。为了阐明 LAIR-1 在体内的免疫学功能,我们构建了表达由 LAIR-1 的细胞外结构域与 Ig 标签融合而成的嵌合蛋白(LAIR-1-Ig)的转基因小鼠,该嵌合蛋白作为诱饵通过与内源性 LAIR-1 竞争而起作用。转基因小鼠表现出对接触超敏反应(CHS),即变应性接触性皮炎的实验模型,易感性增加,与增强的半抗原特异性 T 细胞反应相关。当来自半抗原致敏供体小鼠的 T 细胞转移到非致敏受体小鼠中时,用 LAIR-1-Ig 蛋白处理供体或受体小鼠均可加速 CHS,提示 LAIR-1 在致敏和引发半抗原反应性 T 细胞中可能具有负作用。体外实验表明,LAIR-1 降低树突状细胞中白细胞介素-6 和白细胞介素-12 的产生,并抑制初始和记忆 T 细胞的增殖和细胞因子产生以及 G0/G1 细胞周期停滞。总之,我们的研究结果表明,LAIR-1 通过调节抗原呈递细胞和 T 细胞功能在 CHS 中发挥重要的抑制作用。